Nevertheless, our findings imply that NASH, a leading indicator for future liver transplantation worldwide (40, 41), is prone to display a TIM4-low phenotype highly sensitive to IRI-OLT metabolic stress. The gene discussed is TIMD4; the disease is metabolic dysfunction-associated steatohepatitis.